BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34225098)

  • 21. Long-term mortality in a cohort of home-dwelling elderly with mild Alzheimer's disease and Lewy body dementia.
    Oesterhus R; Soennesyn H; Rongve A; Ballard C; Aarsland D; Vossius C
    Dement Geriatr Cogn Disord; 2014; 38(3-4):161-9. PubMed ID: 24732348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A longitudinal study of anxiety and cognitive decline in dementia with Lewy bodies and Alzheimer's disease.
    Breitve MH; Hynninen MJ; Brønnick K; Chwiszczuk LJ; Auestad BH; Aarsland D; Rongve A
    Alzheimers Res Ther; 2016 Jan; 8():3. PubMed ID: 26812908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression.
    van de Beek M; van Steenoven I; van der Zande JJ; Barkhof F; Teunissen CE; van der Flier WM; Lemstra AW
    Mov Disord; 2020 May; 35(5):859-867. PubMed ID: 32048343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Incidence of Recorded Delirium Episodes Before and After Dementia Diagnosis: Differences Between Dementia With Lewy Bodies and Alzheimer's Disease.
    FitzGerald JM; Perera G; Chang-Tave A; Price A; Rajkumar AP; Bhattarai M; O'Brien JT; Ballard C; Aarsland D; Stewart R; Mueller C
    J Am Med Dir Assoc; 2019 May; 20(5):604-609. PubMed ID: 30448339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The individual course of neuropsychiatric symptoms in people with Alzheimer's and Lewy body dementia: 12-year longitudinal cohort study.
    Vik-Mo AO; Giil LM; Borda MG; Ballard C; Aarsland D
    Br J Psychiatry; 2020 Jan; 216(1):43-48. PubMed ID: 31506117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.
    Abdelnour C; van Steenoven I; Londos E; Blanc F; Auestad B; Kramberger MG; Zetterberg H; Mollenhauer B; Boada M; Aarsland D;
    Mov Disord; 2016 Aug; 31(8):1203-8. PubMed ID: 27296778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.
    Rodriguez MJ; Potter E; Shen Q; Barker W; Greig-Custo M; Agron J; Loewenstein D; Duara R
    Alzheimers Dement; 2012 May; 8(3):211-8. PubMed ID: 22546353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting cognitive decline using neuropsychiatric symptoms in prodromal Lewy body dementia: A longitudinal study.
    Wright LM; Donaghy PC; Burn DJ; Taylor JP; O'Brien JT; Yarnall AJ; Matthews FE; Firbank MJ; Thomas AJ; Lawson RA
    Parkinsonism Relat Disord; 2023 Aug; 113():105762. PubMed ID: 37441886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ABC of Alzheimer's disease: cognitive changes and their management in Alzheimer's disease and related dementias.
    Corey-Bloom J
    Int Psychogeriatr; 2002; 14 Suppl 1():51-75. PubMed ID: 12636180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
    Daniele S; Baldacci F; Piccarducci R; Palermo G; Giampietri L; Manca ML; Pietrobono D; Frosini D; Nicoletti V; Tognoni G; Giorgi FS; Lo Gerfo A; Petrozzi L; Cavallini C; Franzoni F; Ceravolo R; Siciliano G; Trincavelli ML; Martini C; Bonuccelli U
    J Alzheimers Dis; 2021; 80(2):885-893. PubMed ID: 33579836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortical changes associated with depression and antidepressant use in Alzheimer and Lewy body dementia: an MRI surface-based morphometric study.
    Lebedev AV; Beyer MK; Fritze F; Westman E; Ballard C; Aarsland D
    Am J Geriatr Psychiatry; 2014 Jan; 22(1):4-13.e1. PubMed ID: 23880336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hippocampal subfields and decline in activities of daily living in Alzheimer's disease and dementia with Lewy bodies.
    Borda MG; Jaramillo-Jimenez A; Tovar-Rios DA; Ferreira D; Garcia-Cifuentes E; Vik-Mo AO; Aarsland V; Aarsland D; Oppedal K
    Neurodegener Dis Manag; 2020 Dec; 10(6):357-367. PubMed ID: 32967534
    [No Abstract]   [Full Text] [Related]  

  • 33. Sedative Load in Community-Dwelling Older Adults with Mild-Moderate Alzheimer's Disease: Longitudinal Relationships with Adverse Events, Delirium and Falls.
    Dyer AH; Murphy C; Lawlor B; Kennelly SP;
    Drugs Aging; 2020 Nov; 37(11):829-837. PubMed ID: 32924095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between polypharmacy and trajectories of cognitive decline in people with dementia: A large representative cohort study.
    Soysal P; Perera G; Isik AT; Onder G; Petrovic M; Cherubini A; Maggi S; Shetty H; Molokhia M; Smith L; Stubbs B; Stewart R; Veronese N; Mueller C
    Exp Gerontol; 2019 Jun; 120():62-67. PubMed ID: 30831202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On gaps of clinical diagnosis of dementia subtypes: A study of Alzheimer's disease and Lewy body disease.
    Wei H; Masurkar AV; Razavian N
    Front Aging Neurosci; 2023; 15():1149036. PubMed ID: 37025965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer's disease and Parkinson's disease: a large-scale multi-trait association analysis.
    Guo P; Gong W; Li Y; Liu L; Yan R; Wang Y; Zhang Y; Yuan Z
    BMC Med; 2022 Jun; 20(1):214. PubMed ID: 35729600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Alzheimer's disease and Lewy body disease on subcortical atrophy.
    Yoo HS; Lee EC; Chung SJ; Lee YH; Lee SG; Yun M; Lee PH; Sohn YH; Seong JK; Ye BS
    Eur J Neurol; 2020 Feb; 27(2):318-326. PubMed ID: 31487756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M; Gelpi E; Martí MJ; Compta Y
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrasts Between Patients With Lewy Body Dementia Syndromes and APOE-ε3/ε3 Patients With Late-onset Alzheimer Disease Dementia.
    Oliveira FF; Machado FC; Sampaio G; Marin SM; Chen ES; Smith MC; Bertolucci PH
    Neurologist; 2015 Aug; 20(2):35-41. PubMed ID: 26280289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding factors associated with the trajectory of subjective cognitive complaints in groups with similar objective cognitive trajectories.
    Cacciamani F; Bercu A; Bouteloup V; Grasset L; Planche V; Chêne G; Dufouil C;
    Alzheimers Res Ther; 2023 Nov; 15(1):205. PubMed ID: 37993894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.